Related Experiment Videos
Screening for non-insulin-dependent diabetes mellitus
1Department of Family Medicine, SUNY, Stony Brook.
Primary Care
|June 1, 1988
Summary
Screening adults for non-insulin-dependent diabetes mellitus (NIDDM) is debated due to conflicting evidence on treatment benefits. The psychosocial impact of labeling asymptomatic individuals requires further investigation.
Area of Science:
- Endocrinology
- Preventive Medicine
- Public Health
Background:
- Conflicting evidence exists regarding the benefits of early detection and treatment for non-insulin-dependent diabetes mellitus (NIDDM) complications.
- Obesity and hypertension are risk factors for NIDDM and contribute to early atherosclerosis, necessitating treatment regardless of concurrent NIDDM diagnosis.
Purpose of the Study:
- To examine the challenges and considerations surrounding screening recommendations for NIDDM in adults.
- To explore the potential psychosocial repercussions of diagnosing asymptomatic individuals with NIDDM.
Main Methods:
- Literature review and synthesis of existing evidence on NIDDM screening, treatment, and patient labeling.
- Analysis of studies on the impact of labeling in related conditions, such as hypertension.
Main Results:
- The decision to screen for NIDDM is influenced by differing views on treatment goals, particularly glycemic control and the use of oral hypoglycemic agents.
- No direct studies were found on the labeling effects for NIDDM patients, but hypertension studies show increased absenteeism linked to awareness and low compliance.
Conclusions:
- The recommendation for NIDDM screening hinges on the balance between potential treatment benefits and the psychosocial consequences of labeling asymptomatic individuals.
- Further research is needed to understand the impact of labeling on employment, insurance, and overall well-being in the context of NIDDM.